第一作者单位：[1]Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
通讯作者：
推荐引用方式(GB/T 7714)：
Meng Guangqiang,Wang Jing-Shi,Wang Xin-Kai,et al.RUXOLITINIB TREATMENT FOR STEROID-REFRACTORY ACUTE GVHD IN PATIENTS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSOS UNDERGOING ALLO-HSCT[J].PEDIATRIC BLOOD & CANCER.2020,67:S20-S20.
APA：
Meng, Guangqiang,Wang, Jing-Shi,Wang, Xin-Kai,Wang, Yi-Ni&Wang, Zhao.(2020).RUXOLITINIB TREATMENT FOR STEROID-REFRACTORY ACUTE GVHD IN PATIENTS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSOS UNDERGOING ALLO-HSCT.PEDIATRIC BLOOD & CANCER,67,
MLA：
Meng, Guangqiang,et al."RUXOLITINIB TREATMENT FOR STEROID-REFRACTORY ACUTE GVHD IN PATIENTS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSOS UNDERGOING ALLO-HSCT".PEDIATRIC BLOOD & CANCER 67.(2020):S20-S20
